Abstract:The Keap1/Nrf2/ARE pathway controls a network of cytoprotective genes that defend against the damaging effects of oxidative and electrophilic stress, and inflammation. Induction of this pathway is a highly effective strategy in combating the risk of cancer and chronic degenerative diseases, including atherosclerosis and neurodegeneration. An acetylenic tricyclic bis(cyano enone) bearing two highly electrophilic Michael acceptors is an extremely potent inducer in cells and in vivo. We demonstrate spectroscopically that both cyano enone functions of the tricyclic molecule react with cysteine residues of Keap1 and activate transcription of cytoprotective genes. Novel monocyclic cyano enones, representing fragments of rings A and C of the tricyclic compound, reveal that the contribution to inducer potency of the ring C Michael acceptor is much greater than that of ring A, and that potency is further enhanced by spatial proximity of an acetylenic function. Critically, the simultaneous presence of two cyano enone functions in rings A and C within a rigid three-ring system results in exceptionally high inducer potency. Detailed understanding of the structural elements that contribute to the reactivity with the protein sensor Keap1 and to high potency of induction is essential for the development of specific and selective lead compounds as clinically relevant chemoprotective agents. The Keap1/Nrf2/ARE pathway controls a network of cytoprotective genes that defend against the damaging effects of oxidative and electrophilic stress, and inflammation. Induction of this pathway is a highly effective strategy in combating the risk of cancer and chronic degenerative diseases, including atherosclerosis and neurodegeneration. An acetylenic tricyclic bis(cyano enone) bearing two highly electrophilic Michael acceptors is an extremely potent inducer in cells and in vivo. We demonstrate spectroscopically that both cyano enone functions of the tricyclic molecule react with cysteine residues of Keap1 and activate transcription of cytoprotective genes. Novel monocyclic cyano enones, representing fragments of rings A and C of the tricyclic compound, reveal that the contribution to inducer potency of the ring C Michael acceptor is much greater than that of ring A, and that potency is further enhanced by spatial proximity of an acetylenic function. Critically, the simultaneous presence of two cyano enone functions in rings A and C within a rigid three-ring system results in exceptionally high inducer potency. Detailed understanding of the structural elements that contribute to the reactivity with the protein sensor Keap1 and to high potency of induction is essential for the development of specific and selective lead compounds as clinically relevant chemoprotective agents.

Electrophilic metabolites targeting the KEAP1/NRF2 partnership

Abstract 4061: Depleting the cellular level of glutathione and subsequently S -glutathionylation of keap1 by electrophilic agents activates keap1-nrf2 pathway

Abstract 4061: Depleting the cellular level of glutathione and subsequently<i>S</i>-glutathionylation of keap1 by electrophilic agents activates keap1-nrf2 pathway

KEAP1, a cysteine-based sensor and a drug target for the prevention and treatment of chronic disease

Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases

Molecular Basis of the KEAP1-NRF2 Signaling Pathway

Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products

Post-translational modifications of Keap1: the state of the art

The Keap1–Nrf2 system as an in vivo sensor for electrophiles

Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway

Endogenous electrophiles and peroxymonocarbonate can link tyrosine phosphorylation cascades with the cytosolic TXNRD1 selenoprotein and the KEAP1/NRF2 system

An Exceptionally Potent Inducer of Cytoprotective Enzymes

Molecular basis of the Keap1–Nrf2 system

Epigenetic Regulation of Keap1-Nrf2 Signaling

Signal amplification in the KEAP1-NRF2-ARE antioxidant response pathway

Recent progress on small-molecule inhibitors of Nrf2-Keap1 protein-protein interaction

Beyond repression of Nrf2: An update on Keap1

The cytoprotective role of the Keap1–Nrf2 pathway

Nrf2/Keap1/ARE signaling: Towards specific regulation

Downregulation of Keap1 Confers Features of a Fasted Metabolic State

The KEAP1-NRF2 pathway: Targets for therapy and role in cancer